21 May 2009
Serum levels of tromboxane B2 in children after liver transplantation
J Pawłowska, A Wierzbicka, P Socha, I Jankowska, M Teisseyre, J Teisseyre, J SochaAnn Transplant 2009; 14(1): 44-45 :: ID: 880361
Abstract
Background: To describe the patomechanism of liver damage in children after liver transplantation, including lipid metabolism and oxidative stress. The aim of the study was to assess serum tromboxane B2 levels, lipid parameters and glutathione levels in children after liver transplantion and in healthy controls.
Material/Methods: We studied 75 children after liver transplantation (mean 11.7±5.17 y) with normal liver function, and 77 healthy controls (mean 13.0± 3,6 y).
Results: There were significant differences between children after liver
transplantation and healthy controls in tromboxane B2 (TXB2) levels (8.0-180.0 vs. 7-38.0 pg/ml); [lower-upper quartile], HDL-C (45-61 vs. 42.5-56.0 mg/dl), apolipoprotein A1 (1.38-1.59 vs. 1.12-1.52 g/l) and glutathione (GSH) (558.3-754.1 vs. 745.6-800.2 μmol/ml). Transplanted children had significantly higher tromboxane B2, lipoprotein HDL-C and apolipoprotein A1 concentrations than control children. Both groups presented with similar levels of T-CH, TG, LDL-C, VLDL-C, GPx, Lp(a) and Apo B.
Conclusions: The significantly increased serum tromboxane B2 concentration in children after liver transplantation may point to ongoing inflammation which is not reflected by abnormal liver tests. The study received financial support of the Polish Ministry of Science PB 1977/P01/2007/32.
Keywords: Liver Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






